The adverse public health effects of non-medical cannabis legalisation in Canada and the USA
The Lancet Public Health,
Год журнала:
2025,
Номер
10(2), С. e148 - e159
Опубликована: Фев. 1, 2025
SummaryCannabis
consumption
is
legally
prohibited
in
most
countries
the
world.
Several
are
legalising
cannabis
for
adult
consumption.
It
important
to
monitor
public
health
effects
of
these
policy
changes.
In
this
paper,
we
summarise
evidence
date
on
legalisation
non-medical
use
Canada
and
USA.
We
describe
regulatory
models
legalisation,
changes
products
pricing,
illicit
market,
use,
cannabis-related
physical
mental
harms.
discuss
challenges
assessing
outcomes
emphasise
importance
continuous
rigorous
monitoring
adverse
inform
design
policies
regulations.
Язык: Английский
Prevalence of cannabidiol use and correlates in U.S. adults
Drug and Alcohol Dependence Reports,
Год журнала:
2024,
Номер
13, С. 100289 - 100289
Опубликована: Окт. 9, 2024
Cannabidiol
(CBD)
use
has
been
increasing
for
its
putative
therapeutic
potential
various
health
conditions.
Research
using
a
nationally
representative
sample
is
needed
to
examine
characteristics
of
CBD
users.
Data
came
from
the
adult
(N=47,100)
2022
U.S.
National
Survey
on
Drug
Use
and
Health.
We
fitted
generalized
linear
models
sociodemographic,
health,
other
substance
use,
cannabis
risk
perception
as
correlates
CBD-only
CBD-cannabis
co-use,
compared
cannabis-only
use.
In
2022,
20.6
%
23.0
adults
reported
cannabis,
respectively,
in
preceding
12
months,
63
users
also
used
cannabis.
was
significantly
higher
among
women
(CBD-only
vs.
use:
IRR=1.43,
95
CI=1.31-1.57),
but
lower
Black
Hispanic
individuals
non-Hispanic
White
IRR=0.71,
CI=0.60-0.85
individuals;
IRR=0.79,
CI=0.65-0.96
individuals).
Older
ages,
SES,
chronic
medical
conditions,
mental
illness,
high
were
associated
with
likelihood
versus
co-users
at
most
terms
disorder,
problems.
The
prevalence
self-reported
those
physical
problems
warrants
public
warnings
about
side
effects
drug
interactions.
co-use
rate
calls
more
research
benefits
negative
co-use.
Язык: Английский
Innovation and Technology in Medicinal Cannabis and Hemp Value Chains: Opportunities and Perception Challenges for SME Development in Botswana
Kelebogile Kenalemang,
Tshepang Molosiwa
Modern Economy,
Год журнала:
2025,
Номер
16(03), С. 419 - 432
Опубликована: Янв. 1, 2025
Язык: Английский
Health, safety, and socioeconomic impacts of cannabis liberalization laws: An evidence and gap map
Campbell Systematic Reviews,
Год журнала:
2023,
Номер
19(4)
Опубликована: Окт. 30, 2023
Abstract
Background
Globally,
cannabis
laws
and
regulations
are
rapidly
changing.
Countries
increasingly
permitting
access
to
under
various
decriminalization,
medicalization,
legalization
laws.
With
strong
economic,
public
health,
social
justice
incentives
driving
these
domestic
policy
reforms,
liberalization
trends
bound
continue.
However,
despite
a
large
growing
body
of
interdisciplinary
research
addressing
the
policy‐relevant
safety,
socioeconomic
consequences
liberalization,
there
is
lack
robust
primary
systematic
that
comprehensively
investigates
reforms.
Objectives
This
evidence
gap
map
(EGM)
summarizes
empirical
on
policies.
Primary
objectives
were
develop
conceptual
framework
linking
policies
relevant
outcomes,
descriptively
summarize
evidence,
identify
areas
concentration
gaps.
Search
Methods
We
searched
for
eligible
English‐language
studies
published
across
23
academic
databases
11
gray
literature
sources
through
August
2020.
Additions
pool
potentially
from
supplemental
made
November
Selection
Criteria
The
this
EGM
draws
upon
legal
epidemiological
perspective
highlighting
causal
effects
law
population‐level
outcomes.
Eligible
interventions
include
create
or
expand
decriminalized
supply
cannabis:
comprehensive
medical
(MCLs),
limited
cannabidiol
(CBDLs),
recreational
(RCLs),
industrial
hemp
(IHLs),
decriminalization
cultivations
(DCLs).
outcomes
intermediate
responses
(i.e.,
attitudes/behaviors
markets/environments)
longer‐term
(health,
outcomes)
Data
Collection
Analysis
Both
dual
screening
data
extraction
performed
with
third
person
deconfliction.
appraised
using
Maryland
Scientific
Scale
reviews
assessed
AMSTAR
2.
Main
Results
includes
447
studies,
comprising
438
nine
reviews.
Most
derives
United
States,
little
other
countries.
By
far,
most
focuses
MCLs
RCLs.
Studies
targeting
laws—including
CBDLs,
IHLs,
DCLs—are
relatively
rare.
Of
113
distinct
we
documented,
use
was
single
frequently
investigated.
More
than
half
addressed
by
three
fewer
substantial
gaps
in
literature.
base
small,
just
seven
completed
(3),
opioid‐related
harms
alcohol‐related
(1).
Moreover,
have
confidence
reviews,
as
five
minimal
quality
two
low
quality.
Authors’
Conclusions
needed
better
understand
longer‐term—and
arguably
more
salient—health,
Since
concerns
RCLs,
critical
need
societal
impacts
production,
CBD
products,
cultivation.
Future
should
also
prioritize
understanding
heterogeneous
given
differences
specific
provisions
implementation
jurisdictions.
Язык: Английский
Metabolic management of accidental intoxication
Current Opinion in Clinical Nutrition & Metabolic Care,
Год журнала:
2024,
Номер
27(2), С. 147 - 154
Опубликована: Янв. 17, 2024
Purpose
of
review
Unintentional
intoxication
comprises
a
major
chunk
all
intoxications.
Most
patients
are
in
the
pediatric
age
group
with
another
set
being
elderly.
Substances
found
to
cause
accidental
vary
from
country
and
even
within
different
regions
country.
Frequent
reviews
current
literature
needed
be
abreast
trends.
Recent
findings
Prescription
drugs
household
chemicals
culprits
when
it
comes
intoxication.
Acetaminophen,
digoxin
metformin
some
prominent
prescription
frequently
associated
unintentional
Increasingly
alcohol
based
hand
sanitizers
becoming
an
important
etiology
these
events,
following
their
increased
usage
during
COVID-19
pandemic.
Pattern
recognition
identify
class
intoxicant
supportive
care
including
prevention
further
absorption
excretion
cornerstones
therapy.
Antidote
available
should
used
promptly.
Summary
Knowledge
about
epidemiology
intoxications,
toxidrome
pattern
appropriate
antidote
beside
adequate
timely
help
successful
management
unfortunate
victim
Язык: Английский
Comprehensive Review of Phytochemical Studies and Legalization of Cannabis in Morocco
Natural Resources for Human Health,
Год журнала:
2024,
Номер
4(4), С. 398 - 414
Опубликована: Сен. 24, 2024
Research
on
cannabis
and
its
bioactive
derivatives,
including
cannabinoids,
non-cannabinoids,
extracts,
has
significantly
increased
in
recent
years
due
to
their
potential
therapeutic
applications
as
demonstrated
by
numerous
published
studies.
Although
there
is
evidence
of
the
efficacy
cannabinoid
non-cannabinoid
compounds
from
treatment
various
diseases
syndromes,
further
research
required
mitigate
damage
that
could
result
excessive
use
products,
particularly
tetrahydrocannabinol
(THC),
such
psychotropic
effects,
addiction,
cognitive
deficits,
cardiovascular
problems,
impacts
mental
health.
This
review
describes
phytochemical
biological
studies
grown
Morocco,
utilizing
databases
SciFinder,
ScienceDirect,
Scopus,
Google
Scholar,
PubMed
provide
updated
data
Morocco.
The
findings
this
aim
enable
investors,
economic
operators,
researchers,
policymakers
better
understand
current
state
thereby
promoting
industry
growth
cannabis-related
innovation.
Additionally,
paper
includes
a
brief
discussion
legalization
highlighting
new
opportunities
for
investment
medical
cannabis.
study
also
underscores
much
remains
be
explored
regarding
Moroccan
cannabis,
isolation
pre-clinical
clinical
trials
mass
production
approved
cannabis-based
medicines.
Furthermore,
are
intended
inform
key
stakeholders
about
fostering
Язык: Английский